X0708 D LIVE 0002156105 GevRx Nutraceuticals, Inc. 20 MARBLE LOOP SUITE 2A STATEN ISLAND NY NEW YORK 10309 (917) 939-9424 DELAWARE None None Corporation true 2026 James Thomas Christopher 20 Marble Loop Suite 2A Staten Island NY NEW YORK 10309 Executive Officer Director President, Secretary and Treasurer Douglas Spiel, M.D. 20 Marble Loop Suite 2A Staten Island NY NEW YORK 10309 Executive Officer Director Chief Executive Officer and Chief Medical Director Mary Stephen Esposito 20 Marble Loop Suite 2A Staten Island NY NEW YORK 10309 Director Dylan Tyler Spiel 20 Marble Loop Suite 2A Staten Island NY NEW YORK 10309 Executive Officer Vice President Michael J. Betley, Ph.D. 20 Marble Loop Suite 2A Staten Island NY NEW YORK 10309 Executive Officer Chief Scientific Officer Biotechnology Decline to Disclose 06b false 2026-09-11 false true false 0 3000000 300000 2700000 The total offering amount reflects the gross proceeds to be received assuming sale of 300,000 shares of common stock, par value $0.001 per share, of the Company, at a price of $10.00 per share. false 1 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false GevRx Nutraceuticals, Inc. /s/ James Christopher James Christopher President, Secretary and Treasurer 2026-09-18